Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ovid Therapeutics (OVID) Assets (2020 - 2025)

Historic Assets for Ovid Therapeutics (OVID) over the last 6 years, with Q3 2025 value amounting to $63.8 million.

  • Ovid Therapeutics' Assets fell 3780.27% to $63.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $63.8 million, marking a year-over-year decrease of 3780.27%. This contributed to the annual value of $92.2 million for FY2024, which is 3600.71% down from last year.
  • According to the latest figures from Q3 2025, Ovid Therapeutics' Assets is $63.8 million, which was down 3780.27% from $77.4 million recorded in Q2 2025.
  • In the past 5 years, Ovid Therapeutics' Assets ranged from a high of $237.5 million in Q1 2021 and a low of $63.8 million during Q3 2025
  • Moreover, its 5-year median value for Assets was $143.4 million (2023), whereas its average is $145.4 million.
  • Per our database at Business Quant, Ovid Therapeutics' Assets surged by 38064.79% in 2021 and then crashed by 3795.9% in 2025.
  • Over the past 5 years, Ovid Therapeutics' Assets (Quarter) stood at $194.5 million in 2021, then fell by 20.19% to $155.3 million in 2022, then fell by 7.24% to $144.0 million in 2023, then crashed by 36.01% to $92.2 million in 2024, then crashed by 30.73% to $63.8 million in 2025.
  • Its last three reported values are $63.8 million in Q3 2025, $77.4 million for Q2 2025, and $81.7 million during Q1 2025.